» Polvere HGH cruda » Buy HGH 176/191 Freeze-Dried Powder
Buy HGH 176/191. AASraw Gear Biochemical Technology Co., Ltd supplies HGH Fragment 176–191 freeze-dried powder to qualified laboratories, research institutions and authorized chemical distributors
inchiestaBuy HGH 176/191. AASraw Gear Biochemical Technology Co., Ltd supplies HGH Fragment 176–191 freeze-dried powder to qualified laboratories, research institutions and authorized chemical distributors. Customers looking to Buy HGH 176/191 can request current batch specifications, analytical documentation, packaging options and permitted shipping information.
More accurately written as HGH Fragment 176–191, this synthetic research peptide corresponds to the C-terminal amino-acid region of human growth hormone. It contains 16 amino-acid residues and is chemically distinct from full-length, 191-amino-acid somatropin.
Important: HGH Fragment 176–191 is an investigational research peptide. It is not an approved medicine, finished pharmaceutical product or dietary supplement and is not intended for direct human or veterinary use.
HGH Fragment 176–191 is a short synthetic peptide based on amino-acid residues 176 through 191 of human growth hormone. The commonly reported sequence is:
YLRIVQCRSVEGSCGF
The freeze-drying, or lyophilization, process removes water from a frozen peptide preparation under reduced pressure. When properly developed and validated, this process can support the stability, storage and transportation of sensitive research peptides.
HGH Fragment 176–191 should not be confused with somatropin. Somatropin is the complete 191-amino-acid recombinant human growth hormone protein, whereas HGH Fragment 176–191 represents only a short section of that sequence.
Qualified organizations that want to Buy HGH 176/191 should evaluate the product using batch-specific analytical results rather than relying exclusively on a general purity statement.
Depending on the agreed specification, AASraw Gear may provide:
Every order remains subject to customer verification, intended-use review, product availability and destination-country regulations.
C-terminal fragments of human growth hormone have been examined in experimental studies involving metabolic and biochemical pathways. Some early investigations used cell or animal models, meaning their findings cannot establish safety or effectiveness in humans.
HGH Fragment 176–191 must also be distinguished from AOD9604. Although the two names are sometimes used interchangeably in commercial descriptions, AOD9604 is a modified peptide related to the HGH C-terminal region. They should not be treated as identical unless peptide identity, sequence and modification status are clearly established through analytical documentation.
AASraw Gear does not claim that HGH Fragment 176–191 prevents, treats or cures any disease or produces weight-management or performance-enhancement results.
The quality of HGH Fragment 176–191 may be evaluated through a combination of peptide-specific analytical methods. Depending on the applicable specification, testing may include:
HPLC area purity alone does not establish peptide content, sequence identity, biological activity, sterility or suitability for pharmaceutical use. The current batch COA should always be reviewed before procurement.
AASraw Gear Biochemical Technology Co., Ltd supports qualified customers with research-focused peptide supply and technical documentation.
Available services may include:
Qualified laboratories, research institutions and authorized distributors may contact AASraw Gear to Buy HGH 176/191 for lawful research applications. Orders are subject to customer qualification, intended-use review and applicable regulations.
It refers to a synthetic peptide corresponding to amino-acid positions 176 through 191 in the C-terminal region of human growth hormone. It contains 16 amino-acid residues.
NO. Full-length recombinant human growth hormone, or somatropin, contains 191 amino acids. HGH Fragment 176–191 contains only a 16-amino-acid segment derived from that protein.
Depending on the batch and agreed specification, customers may request a COA containing identity, HPLC purity, mass analysis, peptide content or other available test results.
Not necessarily. AOD9604 is a modified peptide associated with the C-terminal region of HGH. Buyers should check the documented sequence, terminal modifications, molecular mass and analytical results to distinguish the materials.
Freeze-drying removes water under controlled conditions and can help support peptide stability. The effectiveness of the process depends on the formulation, packaging and validated storage conditions.
Temperature requirements depend on the exact product formulation and available stability data. Customers should follow the batch label and technical documentation rather than applying a universal storage temperature.
A batch-specific COA may be supplied for qualifying orders. Customers should review the stated identity, purity method, peptide content and other relevant results before use.
NO. HPLC area purity describes the relative chromatographic profile under a particular method. It does not necessarily state how much active peptide is present by weight.
NO. It is an investigational research peptide and is not supplied as an approved medicine, dietary supplement or finished injectable product.
Shipment depends on customer eligibility and the customs, import and chemical regulations of the origin, transit and destination countries. Buyers must confirm that purchase, importation and research use are lawful.
Qualified organizations seeking to Buy HGH 176/191 can contact AASraw Gear Biochemical Technology Co., Ltd for current availability, batch specifications, analytical documentation, packaging options and permitted shipping destinations.
Please include your organization’s information, required quantity, destination country, intended research application and requested quality tests when submitting an inquiry.
For laboratory and analytical research only. Not a finished medicine and not for direct human or veterinary use.
| Item | General Specification |
|---|---|
| Product name | HGH Fragment 176–191 |
| Common search names | HGH 176/191, HGH Frag 176–191 |
| Product category | Synthetic research peptide |
| Amino-acid length | 16 residues |
| Reference sequence | YLRIVQCRSVEGSCGF |
| Molecular weight | Approximately 1.8 kDa; confirm for the exact peptide form |
| Typical appearance | White to off-white freeze-dried powder or cake |
| Identity | Confirmed using an appropriate peptide-identification method |
| Purity | According to the batch-specific COA and stated method |
| Peptide content | According to the applicable batch specification |
| Modification status | Must be confirmed in the product documentation |
| Intended application | Laboratory and analytical research only |
| Packaging | Subject to quantity and stability requirements |
| Shipping conditions | Based on documented product-stability requirements |
The molecular weight and other chemical details can differ according to sequence modifications, terminal groups, salt form, counterions and disulfide status. The batch-specific specification and COA are the controlling documents.
HGH Fragment 176–191 is a short peptide derived from the C-terminal region of the full human growth hormone sequence. Its 16-residue structure makes it substantially smaller than full-length somatropin, which contains 191 amino acids and has a molecular weight of approximately 22.1 kDa.
The product is generally supplied as a white to off-white lyophilized powder or cake. Differences in texture or cake structure may result from the formulation and freeze-drying process. Appearance alone cannot confirm purity, identity or stability.
Solubility depends on the peptide’s precise sequence, modification status, salt form, pH, buffer composition and concentration. Suitability must be established experimentally using validated laboratory procedures.
Peptide integrity may be affected by heat, moisture, oxidation, light, contamination and repeated temperature changes. Freeze-drying can improve physical stability, but it does not make the material permanently stable or eliminate the need for controlled storage.
HGH Fragment 176–191 remains an investigational compound. Research findings involving related HGH fragments or AOD9604 should not automatically be attributed to this exact peptide.
Store HGH Fragment 176–191 under the conditions stated on its product label, Certificate of Analysis and stability documentation. Keep the container sealed and protect the freeze-dried material from heat, moisture, direct light and contamination.
Recommended laboratory controls include:
The required storage temperature, allowable excursions and retest period must be supported by product-specific stability data. Do not assign a shelf life based only on the material’s freeze-dried appearance.
HGH Fragment 176–191 may be supplied in research-scale or bulk packaging according to customer eligibility and project requirements. Packaging may include sealed primary containers, moisture-protective secondary packaging and insulated shipping materials.
Where supported by the stability requirements, shipment may use:
Customers should inspect the package immediately after delivery and review any available temperature-monitoring information before accepting the material for research.
